Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion
Annals of Internal Medicine · 2023
DOI: 10.7326/m22-2568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Ning Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: ICES and University of Toronto, Toronto, Ontario, Canada (N.L.). Hauptthemen laut MEDLINE: Misoprostol, Abortion, Induced, Abortion, Spontaneous. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: CIHR.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ICES and University of Toronto, Toronto, Ontario, Canada (N.L.).
- Departments of Medicine and Obstetrics and Gynecology, St. Michael's Hospital, ICES, and University of Toronto, Toronto, Ontario, Canada (J.G.R.).
ORCID-Profile: Ning Liu, Joel G Ray
Förderung
- CIHR
Zitieren
APA
Liu, N., & Ray, J. G. (2023). Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion. Annals of Internal Medicine. https://doi.org/10.7326/m22-2568
Vancouver
Liu N, Ray JG. Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion. Annals of Internal Medicine. 2023. doi:10.7326/m22-2568
BibTeX
@article{Liu2023,
author = {Liu, Ning and Ray, Joel G},
title = {Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion},
journal = {Annals of Internal Medicine},
year = {2023},
doi = {10.7326/m22-2568}
}
EUVIMED